ALPHA 1 BIOMEDICALS INC
10QSB, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: ALPHA 1 BIOMEDICALS INC, 10QSB, 2000-11-14
Next: LAM RESEARCH CORP, 10-K405/A, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         344,087
<SECURITIES>                                   681,569
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,025,656
<PP&E>                                           3,123
<DEPRECIATION>                                   1,782
<TOTAL-ASSETS>                               1,027,962
<CURRENT-LIABILITIES>                          206,761
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        19,477
<OTHER-SE>                                     801,724
<TOTAL-LIABILITY-AND-EQUITY>                   821,201
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               292,405
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                366,912
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            366,912
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                781,775
<CHANGES>                                            0
<NET-INCOME>                                 1,148,687
<EPS-BASIC>                                        .02
<EPS-DILUTED>                                      .06


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission